Phlegmasia cerulea dolens: a swelling, cyanosis and discolouration of the extremity in the ICU

  1. João Alves ,
  2. Andrea Salgueiro ,
  3. João Pedro Baptista and
  4. Paulo Coimbra
  1. Intensive Care Medicine, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal
  1. Correspondence to Dr João Alves; jpbmalves@gmail.com

Publication history

Accepted:16 Nov 2022
First published:29 Nov 2022
Online issue publication:29 Nov 2022

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

Phlegmasia cerulea dolens is a rare entity that causes critical limb ischaemia, which may lead to amputation of the limb and may be life-threatening. Here, we describe a case of a healthy man in his 50s with multiple trauma who was transferred to the intensive care unit (ICU) of a central hospital for neuromonitoring following splenectomy for the stabilisation of a hypovolaemic shock. On admission to the ICU, the patient developed a swollen and white leg. The condition was caused by early compromised arterial flow secondary to extensive deep vein thrombosis.

Background

Phlegmasia cerulea dolens (PCD) is characterised by an extensive deep vein thrombosis (DVT) that compromises the arterial flow of the superficial and collateral circulation and progressively leads to venous gangrene. Given the scarcity of cases, the precise incidence of PCD is unknown. However, clinicians, especially those who work in the intensive care unit (ICU), should be aware of PCD. ICU patients may be at greater risk of PCD due to the complexity of these patients and their susceptibility to frequent complications, such as severe congestion and fluid sequestration of the limb, leading to venous hypertension, circulatory shock, arterial insufficiency or other thromboembolic events.1 2 The typical clinical presentation of PCD is a cold, swollen, painful and cyanotic lower extremity.3 The dorsal foot and posterior tibial pulses are not palpable. Vascular ultrasound can enhance the absence of the pulse to confirm the diagnosis. Initial treatment usually involves medical thrombolysis and conservative management methods.

In patients with contraindications to medical treatment or therapeutic failure, there are two other treatment options, namely, endovascular or surgical. Catheter-directed thrombolysis is the recommended endovascular treatment for restoring venous flow. Surgical thrombectomy is an emergent treatment.4 Given the high risk of complications that can lead to the patient’s death, PCD requires rapid diagnosis and immediate treatment.

Case presentation

An otherwise healthy man in his 50s suffered multiple trauma. He was admitted to the ICU with traumatic brain injury (TBI) with foci of contusion, subarachnoid haemorrhage (SAH) and diffuse oedema. Intracranial pressure sensor monitoring was put in place, and antioedematous treatment was provided. Chest trauma was also present with fracture of three ribs on the right. Hypovolaemic shock secondary to the rupture of the spleen required emergent splenectomy. Thromboprophylaxis with compression stockings was commenced immediately, and low molecular weight heparin (LMWH) was started from day 6 of hospital admission.

On day 11 of hospitalisation, the right lower limb showed oedema, skin tension and paleness, and the popliteal and pedal pulses were undetectable (figure 1). Bedside vascular ultrasound showed the absence of vascular flow in the femoral and iliac territories. CT angiography indicated extensive DVT of the external iliac and femoral veins, constricted by a central venous catheter, and PCD was diagnosed (figure 2). Emergency venous thrombectomy of the right lower limb was performed via the femoral route (figure 3) resulting in a drastic reduction in lower limb tension at the end of surgery (figure 4). Hence, fasciotomy was not performed.

Figure 1

Patient’s lower limb in the acute phase of thrombus presentation.

Figure 2

Thrombosis of the right femoral vein and right external iliac vein, with marked thickening of the musculocutaneous muscle planes.

Figure 3

Thrombus identified intraoperatively.

Figure 4

Patient’s lower limb with total limb reperfusion postoperation.

Perioperatively, the patient was haemodynamically stable and did not require vasopressor support. Hyperlactataemia was not evident (maximum value=0.98 mmol/L), and no signs of acute kidney damage were observed. Postoperatively, haemoglobin was 64 g/L, and erythrocyte concentrate was transfused. The maximum peak creatine kinase was 886 U/L.

On day 14 of ICU admission, the patient developed a thrombotic event in the cephalic vein of the left upper limb. The embolus measured 3 cm. The radial pulse was palpable, and no external signs of phlebitis were observed. Specific interventions were not indicated. Prophylactic LMWH was maintained. The clinical course progressed favourably, and the patient was transferred to the ward on day 24. The Glasgow Coma Scale score of the patient was 14 (E4, M6 and V4). The LMWH dosage was monitored, with anti-Xa measurements during the hospital stay, and the values were maintained within the prophylactic range.

Treatment

There is no consensus for PCD management; however, several options may be considered, including limb elevation, heparin and intravenous administration of a thrombolytic agent. In critically ill patients hospitalised mainly for trauma or hypovolaemic shock, patient mobilisation may be affected, and adequate antithrombotic prophylaxis or therapeutic anticoagulation may not be possible. If these conservative options are contraindicated, surgical venous thrombectomy is recommended as the first-line treatment.5

In the present case, elastic compression bandages were applied to the patient following thrombectomy, and the LMWH was maintained at a prophylactic dose due to a high bleeding risk.

Outcome and follow-up

Our patient was discharged to the neurosurgery department after 24 days in the ICU. After a further 29 days in the ward, the patient was transferred to a rehabilitation centre. The patient was followed up for 9 months after being discharged from the hospital. The 9-month follow-up ultrasound doppler confirmed deep venous system permeability (figure 5). Clinically, the patient reported pain, and oedema was evident in the right lower limb. Improvements were achieved with compression stockings. Anticoagulation with 2.5 mg apixaban was maintained for another 3 months to prevent post-thrombotic syndrome.

Figure 5

Doppler of the affected lower limb at the 9-month follow-up after hospital discharge.

Discussion

PCD is a spectrum that includes DVT, phlegmasia alba dolens (PAD) and venous gangrene.

PCD is an uncommon, severe form of DVT that affects the central and lateral veins of the extremities. Clinically, PCD presents as severe purple discolouration and oedema accompanied by pain. Increased venous congestion caused by PCD increases the pressure of the limb, and a circulatory shock may result due to fluid sequestration.

The main factors that increase the risk of PCD are DVT due to injury to the lining of the vein, high tendency to form blood clots and reduced blood flow. Aggravating factors in critically ill patients include reduced mobility, predisposition to prothrombotic states or contraindications, both physical and therapeutic, precluding antithrombotic prophylaxis.

In patients with TBI, such as that in the present case, the early introduction of prophylaxis (≤48 hours) can minimise the risks of developing severe DVT without increasing haemorrhagic complications.6 7

PCD has a typical presentation. Pain, swelling and cyanosis progressively worsen over a few hours to several days. Pain is secondary to compartment pressure due to increased venous hypertension of the affected extremity.8 In intensive care patients, pain may be masked. Instead, other clinical manifestations such as tachycardia, diffuse sweating and hypertension may be observed.9

PCD is a rare entity, even in ICU. Few cases have been reported in the literature. Therefore, the incidence of the disease is unknown. Lessne et al estimated a mortality rate of 20%–25% in the presence of hypovolaemic shock and other complications, such as pulmonary thromboembolism, reperfusion syndrome, compartment syndrome, rhabdomyolysis, acute kidney injury or multiorgan failure.10 In addition, Chaochankit et al reported a 20%–50% incidence of amputation in patients with PCD.11

In the vast majority of the described cases, the initial treatment involved the elevation of the limb, intravenous fluid therapy and anticoagulation. Thrombectomy (surgical or endovascular) should be part of the decision algorithm. Thrombectomy should be considered the gold standard in specific situations, as in the present case and as described by Butterworth et al.12 Fasciotomies to treat compartment syndrome secondary to DCP or PAD have rarely been reported. In the present case, the rapid diagnosis, prompt surgical decision, immediate availability of an operating theatre and recirculation with reduction of the oedema resulted in adequate improvement without fasciotomy.13 Clinically, we monitored the limb compartment pressure and verified the condition with soft tissue ultrasound and doppler. Few previous cases have reported the resolution of a marked increase in intramuscular pressure by removing the thrombus that obstructed the venous circulation, thereby achieving tissue reperfusion and a decrease in the limb pressure.

However, fasciotomy is indicated if PCD is refractory or if the improvement following medical and conservative management is inadequate. In such instances, fasciotomy is important for preventing gangrene progression, limb amputation or death.

Our patient had important risk factors for DVT, including trauma, surgery and long-term catheters use. Although anticoagulation was indicated, it was postponed due to the risk of cerebral bleeding in our patient who suffered a TBI with foci of contusion and SAH.

In conclusion, PCD can be managed using various therapeutic options. The preferred treatment must take into account the patient’s condition and individual risk factors.

Learning points

  • Phlegmasia cerulea dolens (PCD) is a rare disease that is difficult to diagnose. It can present as an acute and catastrophic event in the intensive care unit patient with trauma.

  • Early deep vein thrombosis prophylaxis is important for preventing thromboembolic events without increasing haemorrhagic risks in patients with TBI.

  • Limb signs, such as pain, oedema and discolouration, in addition to hypovolaemia or haemodynamic instability, constitute clinical features that should serve as warning signs for PCD.

  • In case of suspected PCD, ultrasound doppler should be a priority.

  • Surgical venous thrombectomy may be the first-line treatment in select patients.

Ethics statements

Patient consent for publication

Footnotes

  • Contributors JA: responsible for the design, data acquisition and conception of the article. AS: contribution to article writing. JPB: design and guidance from work conception to submission. PC: global guidance and case correction.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer